Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until February 1, 2026

Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 31, 2025 - Online CME Course

This online CME course is recommended for primary care providers. The course is comprised of Mayo Clinic Talks podcast interviews about the background, medical management, and principles of treatment of child and adolescent eating disorders, including myths, identification and assessment, treatment options, and considerations of working with patients and coaching parents/families. Listen in the course or using your favorite podcast app, then return here to take a short assessment and claim credit.

Available until November 30, 2026 - Online CME Course

This online course offers comprehensive updates in ophthalmology and optometry that can be immediately applied to clinical practice. Topics will include neuro-ophthalmology, glaucoma, retina, cornea and external disease, oculoplastic and orbital surgery, and more.

Available until December 31, 2026 - Online CME Course

Mayo Clinic Application of Quality Improvement: Tools and Methods – Silver Level Knowledge Assessment (formerly Applied Quality Essentials) is a learning and self-assessment activity which aims to evaluate the participant’s knowledge in quality improvement concepts and methods. This Silver Level Knowledge Assessment crosses all disciplines and clinical settings. The following key themes align with ABMS patient safety standards document and are incorporated in the questions and reference material for this module: patient safety, error identification, effect of systems, human factors, communication, culture of safety, methods and tools for evaluating quality and safety events. There are no prerequisites for this course. The module is offered as an online 30-question Pre-test (Test A) and 30-question Post-test (Test B). Test A and Test B are different versions each containing 30 distinct questions testing to the same concepts. The module can be taken as an open book test with an extensive, indexed Study Guide included. Education credit will be awarded if the participant achieves a score ≥80% correct answers on Pre-test (Test A-one chance) or Post-test (Test B-two chances). For Test A, the learner’s choices along with the correct answers for each question will be provided with an overall performance score and relevant references to educational content at the conclusion of the test. For Test B, the learner can choose to display whether the answer was correct or incorrect, with an overall performance score at the conclusion of the test.

Available until September 1, 2024 - Podcast Online CME Education

Natalie T. Hagy, PharmD shares new antifungal agents in the pipeline, their novel mechanisms of action, and available formulations.